Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pilot, Single Center, Open, Trial of Rifaximin in Probable Alzheimer's Disease

NCT03856359 is registered in ClinicalTrials.gov with Duke University as lead sponsor.

NCT NCT03856359
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03856359 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pilot, Single Center, Open, Trial of Rifaximin in Probable Alzheimer's Disease
Lead sponsor
Duke University
Phase
Phase 2
Overall status
Completed
Start date
April 9, 2019
Completion date
November 19, 2020
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer's disease